Non-Discrimination in Cost-Effectiveness Analysis
Author Information
Author(s): Darius N. Lakdawalla, Jason N. Doctor
Primary Institution: University of Southern California
Hypothesis
Can cost-effectiveness analysis be conducted without discrimination against the elderly, disabled, or terminally ill?
Conclusion
The study proposes a new method, GRACE, that aims to assess health interventions without discrimination.
Supporting Evidence
- The US Inflation Reduction Act prohibits discriminatory pricing for prescription drugs.
- Existing metrics like EVL and HYT may lead to inconsistent and discriminatory outcomes.
- GRACE is proposed as a more equitable alternative for cost-effectiveness analysis.
Takeaway
This study looks at how to fairly evaluate health treatments for everyone, especially those who are older or have disabilities.
Methodology
The study compares three metrics: Equal Value of Life-years gained (EVL), Health Years in Total (HYT), and Generalized Risk-Adjusted Cost-Effectiveness (GRACE).
Potential Biases
The study identifies potential biases in existing metrics that could lead to discriminatory outcomes.
Limitations
The proposed methods may still not universally avoid discrimination against the sick and disabled.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website